Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects

12.5 and 50 mg Capsules, anticipated dose range to be from 25 to 250 mg.

Identical capsule to the drug without the active ingredient.